The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
SRRK · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
GTHP · Healthcare · No moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
COYA · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | SRRK | QUCY | GTHP | COYA |
|---|---|---|---|---|
| Moat Score (0–100) | 35 (highest) | 35 (highest) | 35 (highest) | 35 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 60 (highest) | 20 | 53 | 40 |
| Pricing power | — | 94 (highest) | 15 | — |
| Returns on capital | 0 (highest) | 0 (highest) | — | 0 (highest) |
| Balance-sheet safety | 55 (highest) | 28 | 28 | 55 (highest) |
| Capital discipline | 24 | 33 | 44 (highest) | 44 (highest) |
| Price vs. high estimate | No price data | No price data | No price data | No price data |
| Market cap | $5.5B | $11.3M | $23.7M | $92.9M |
| Moat tier | No moat | No moat | No moat | No moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |